Structure of Tyrosine Kinase 2 Scientists have discovered a new drug candidate, TAK-279, which is a highly selective inhibitor of TYK2 enzymatic activity. TYK2 is a key mediator of IL12, IL23, and type I interferon signaling, and these cytokines have been implicated in the pathogenesis o...